Cargando…

Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC

Fibrotic tumor stroma plays an important role in facilitating triple-negative breast cancer (TNBC) progression and chemotherapeutic resistance. We previously reported a rationally designed protein (ProAgio) that targets integrin α(v)β(3) at a novel site. ProAgio induces apoptosis via the integrin. C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Malvika, Turaga, Ravi Chakra, Yuan, Yi, Satyanarayana, Ganesh, Mishra, Falguni, Bian, Zhen, Liu, Wei, Sun, Li, Yang, Jenny, Liu, Zhi-Ren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876552/ https://www.ncbi.nlm.nih.gov/pubmed/33561195 http://dx.doi.org/10.1084/jem.20200712

Ejemplares similares

Pyruvate kinase M2 regulates fibrosis development and progression by controlling glycine auxotrophy in myofibroblasts
por: Satyanarayana, Ganesh, et al.
Publicado: (2021)

P68 RNA Helicase facilitates Breast Cancer progression by promoting Proliferation and Migration via PDGFR-β/AR axis
por: Panchbhai, Neha, et al.
Publicado: (2021)

Modulation of Cancer-Associated Fibrotic Stroma by An Integrin α(v)β(3) Targeting Protein for Pancreatic Cancer Treatment
por: Turaga, Ravi Chakra, et al.
Publicado: (2020)

Targeting integrin αvβ3 by a rationally designed protein for chronic liver disease treatment
por: Turaga, Ravi Chakra, et al.
Publicado: (2021)

Overexpression of Smac by an Armed Vesicular Stomatitis Virus Overcomes Tumor Resistance
por: Li, Weike, et al.
Publicado: (2019)

Early Detection and Staging of Lung Fibrosis Enabled by Collagen-Targeted MRI Protein Contrast Agent
por: Ibhagui, Oluwatosin Y., et al.
Publicado: (2023)

Chemotherapy with ceramide in TNBC
por: Legembre, Patrick, et al.
Publicado: (2015)

GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts
por: Mollah, Farhana, et al.
Publicado: (2021)

Turning up a new pattern: Identification of cancer-associated fibroblast-related clusters in TNBC
por: Xie, Jindong, et al.
Publicado: (2022)

The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020)

Early detection and staging of chronic liver diseases with a protein MRI contrast agent
por: Salarian, Mani, et al.
Publicado: (2019)

Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC
por: Tan, Renbo, et al.
Publicado: (2020)

Evidence for the Effects of Xanthohumol in Disrupting Angiogenic, but not Stable Vessels
por: Negrão, Rita, et al.
Publicado: (2007)

Rational design of a protein that binds integrin α(v)β(3) outside the ligand binding site
por: Turaga, Ravi Chakra, et al.
Publicado: (2016)

The Evaluation of Cytotoxic Properties from CCB-2 Sugar Complexes Against TNBC and Non-TNBC Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2021)

IKKβ Inhibition Attenuates Epithelial Mesenchymal Transition of Human Stem Cell-Derived Retinal Pigment Epithelium
por: Sripathi, Srinivasa R., et al.
Publicado: (2023)

Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs
por: Reddy, Tejaswini P., et al.
Publicado: (2020)

TNBC invasion: downstream of STAT3
por: Jackson, James G., et al.
Publicado: (2017)

On the preservation of vessel bifurcations during flow-mediated angiogenic remodelling
por: Edgar, Lowell T., et al.
Publicado: (2021)

The fate of chemoresistance in triple negative breast cancer (TNBC)
por: O’Reilly, Elma A., et al.
Publicado: (2015)

An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC
por: Zhang, Mengqi, et al.
Publicado: (2023)

Monoethanolamine-induced glucose deprivation promotes apoptosis through metabolic rewiring in prostate cancer
por: Garlapati, Chakravarthy, et al.
Publicado: (2021)

Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the heterogeneity of cancer-associated fibroblasts in TNBC
por: Wu, Xiaoqing, et al.
Publicado: (2023)

“Vessels in the Storm”: Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer
por: Angelucci, Adriano, et al.
Publicado: (2018)

Nanoparticle Delivery of Angiogenic Gene Therapy. Save the Vessels, Save the Lung!
por: Zepp, Jarod A., et al.
Publicado: (2020)

The Potential of PSMA as a Vascular Target in TNBC
por: Heesch, Amelie, et al.
Publicado: (2023)

Aptamer-Based Strategies to Boost Immunotherapy in TNBC
por: Agnello, Lisa, et al.
Publicado: (2023)

Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
por: Chaudhuri, Aiswarya, et al.
Publicado: (2023)

VISTA is associated with immune infiltration and predicts favorable prognosis in TNBC
por: Zhang, Mi, et al.
Publicado: (2022)

Investigation of Candidate Genes and Pathways in Basal/TNBC Patients by Integrated Analysis
por: Liu, Qi, et al.
Publicado: (2021)

Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro
por: Choi, Hoon Sik, et al.
Publicado: (2021)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023)

Cdh1 Deficiency Sensitizes TNBC Cells to PARP Inhibitors
por: Li, Junjun, et al.
Publicado: (2022)

Comparisons of Oncologic Outcomes between Triple-Negative Breast Cancer (TNBC) and Non-TNBC among Patients Treated with Breast-Conserving Therapy
por: Kim, Sanghwa, et al.
Publicado: (2016)

Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target
por: Koni, Malvina, et al.
Publicado: (2022)

LC–MS Based Lipidomics Depict Phosphatidylethanolamine as Biomarkers of TNBC MDA-MB-231 over nTNBC MCF-7 Cells
por: Estrada-Pérez, Alan Rubén, et al.
Publicado: (2022)

MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC
por: Franklin, Derek A., et al.
Publicado: (2020)

Vessel Architectural Imaging Identifies Cancer Patient Responders to Anti-angiogenic Therapy
por: Emblem, Kyrre E., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2eqnelk5vrsbkcv3moq0dbf6l8